CNS Neuroscience & Therapeutics · 2021 · 16 citations · 32 references
MedicineMedicinal ChemistryPharmacologyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyAnxiolytic PharmacologyReceptor PharmacologySerotonergic Pharmacology5-Hydroxytryptamine Receptor PharmacologyAgonist ActivityAntidepressant EfficacySerotonergic MechanismsSerotonin AgonistsSerotonin AntagonistsSerotonin Receptor PharmacologySerotonin Receptor Subtypes
Abstract Aims To evaluate the antidepressant‐like effect of compound GW117 in rodents using in vitro binding and uptake assays as well in vivo behavioral tests. Methods We investigated the target profile of GW117 using [ 35 S]‐GTPγS and [ 3 H]PIP binding. Using the forced swimming test and chronic unpredictable stress in rats, tail suspension test in mice and rats, and learned helplessness model in mice, we further revealed the antidepressant‐like and anxiolytic‐like effects of GW117. Results The current study suggests that GW117 displays serotonin 2C (5‐HT 2C ) receptor antagonist and melatonin type 1 and 2 (MT 1 /MT 2 ) receptor agonist properties, as well as evident antidepressant and anxiolytic effects. Conclusion These data suggest that GW117 is probably a potent antidepressant.
32
The tail suspension test: A new method for screening antidepressants in mice
Lucien Stéru, R Chermat, Bernard Thierry et al. · Psychopharmacology · 1985 · 3.5K citations
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Roger D. Porsolt, Guy Anton, N. Blavet et al. · European Journal of Pharmacology · 1978 · 3.1K citations
Frank P. Bymaster · Neuropsychopharmacology · 2001 · 720 citations · Full text
Medicine, Neuroscience, Pharmacology +17